The Office Tensilon Test for Ocular Myasthenia Gravis
- 1 August 1986
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of Neurology
- Vol. 43 (8) , 843-844
- https://doi.org/10.1001/archneur.1986.00520080081029
Abstract
The technique for intravenous administration of Tensilon (edrophonium chloride) varies. In 1952, Osserman and Genkins1introduced the test and recommended a 2-mg initial dose followed, if no reaction (usually cholinergic) occurred in 45 s, by the rapid administration of an additional 8 mg. Others have modified the test by waiting five minutes after the initial dose,2by injecting Tensilon in small increments after the initial dose,2-6or by slowly infusing the remaining 8 mg.5Although I have recently been converted by Norman Schatz, MD, to the small-increment method, the significant controversy this essay should address is not drug administration but rather the testend point. What constitutes a "positive" Tensilon response in the physician's office where (without benefit of oculographic equipment7-10) the first Tensilon test is performed in a suspected myasthenic? Such a determination is obviously important since a positive test is virtually diagnostic ofKeywords
This publication has 4 references indexed in Scilit:
- Ocular Myasthenia GravisPublished by Elsevier ,2004
- Eye movement fatigue in myasthenia gravisNeurology, 1979
- EDROPHONIUM INFRARED OPTOKINETIC NYSTAGMOGRAPHY IN THE DIAGNOSIS OF MYASTHENIA GRAVISAnnals of the New York Academy of Sciences, 1976
- CRITICAL REAPPRAISAL OF THE USE OF EDROPHONIUM (TENSILON) CHLORIDE TESTS IN MYASTHENIA GRAVIS AND SIGNIFICANCE OF CLINICAL CLASSIFICATION*†Annals of the New York Academy of Sciences, 1966